Top Markets
#1 Akedo Akedo +89.15%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.04%
#4 Cross Cross +45.57%
#5 Black Phoenix Black Phoenix +34.20%
#6 Velvet Velvet +32.22%
#7 Cap Cap +21.97%
#8 OVERTAKE OVERTAKE +20.36%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.91%
#10 QANplatform QANplatform +14.83%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Vivanza Biosciences Limited Vivanza Biosciences Limited

Vivanza Biosciences Limited

VIVANZA
Clasificación en acciones #38721
Vivanza Biosciences Limited is a pharmaceutical firm specializing in the... Vivanza Biosciences Limited is a pharmaceutical firm specializing in the creation and commercialization of medicinal products. Among its offerings, the company prominently features Intravenous (IV) Fusion solutions. This enterprise was founded on March 3, 1982, and maintains its primary operational base in Ahmedabad, India.
Precio por acción
$0.02096817
Capitalización bursátil
$838.73K
Cambio (1 día)
-4.52%
Cambio (1 año)
-12.44%
País
IN
Comercio Vivanza Biosciences Limited (VIVANZA)

Categoría

Healthcare
Ratio P/B de Vivanza Biosciences Limited (VIVANZA)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Vivanza Biosciences Limited, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Vivanza Biosciences Limited desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US